Related Experiment Video

Updated: Jun 5, 2026

Mouse Round Spermatid Injection
08:41

Mouse Round Spermatid Injection

Published on: January 26, 2024

Inositol activity in oligoasthenoteratospermia--an in vitro study

M Colone1, G Marelli, V Unfer

  • 1Department of Technologies and Health, National Institute of Health, Rome, Italy. marisa.colone@iss.it

Abstract

Insights

Inositol shows potential as an antioxidant to improve sperm quality in men with oligoasthenoteratospermia. This natural substance may help restore sperm morphology and motility by protecting mitochondria from oxidative damage.

Area of Science:

  • Reproductive biology
  • Andrology
  • Biochemistry

Background:

  • Oligoasthenoteratospermia is a primary cause of male infertility.
  • Morphologically altered spermatozoa produce reactive oxygen species (ROS), damaging sperm motility, morphology, and DNA.
  • Spermatozoa are particularly vulnerable to ROS-induced damage.

Purpose of the Study:

  • To investigate inositol as a potential antioxidant for male infertility.
  • To assess inositol's efficacy in improving in vitro sperm quality for assisted reproduction.

Main Methods:

  • Sperm samples from infertile and healthy men were analyzed using phase contrast microscopy.
  • Samples were treated with inositol (2 mg/ml) and examined via scanning electron microscopy (SEM) and transmission electron microscopy (TEM).
  • SEM evaluated surface morphology changes; TEM assessed ultrastructural details.

Main Results:

  • Pathological sperm samples showed fibrous material hindering motility and damaged mitochondria with altered cristae.
  • Inositol treatment reduced the fibrous material and improved mitochondrial morphology, with less cristae damage.
  • These changes suggest inositol may alter seminal fluid properties and protect sperm mitochondria.

Conclusions:

  • Inositol exhibits antioxidant properties potentially targeting sperm mitochondria.
  • Preliminary findings suggest inositol's benefit for oligoasthenoteratospermia.
  • Further research is needed to correlate ROS levels, inositol treatment, and oligoasthenoteratospermia outcomes.